Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Biomarkers / CCL27



This biomarker is also known as:
  • chemokine (C-C motif) ligand 27,
  • ILC,
  • C-C motif chemokine 27,
  • CTACK,
  • IL-11 R-alpha-locus chemokine,
  • cutaneous T-cell attracting chemokine,
  • SCYA27,
  • Skinkine,
  • IL-11 Ralpha-locus chemokine,
  • Cutaneous T-cell-attracting chemokine,
  • small-inducible cytokine A27,
  • small inducible cytokine subfamily A (Cys-Cys), member 27,
  • cutaneous T-cell-attracting chemokine,
  • ALP,
  • CC chemokine ILC,
  • CTAK,
  • Small-inducible cytokine A27,
  • PESKY,
  • skinkine,
  • ESkine,

View in BioMuta


CCL27 is a member of the CC cytokine family, and is involved in immunoregulatory and inflammatory processes. CC cytokines are characterized by two adjacent cysteines. CCL27 functions as a chemotactic factor that attracts skin-associated memory T-lymphocytes. CCL27 may also play a role in mediating homing of lymphocytes to cutaneous sites. CCL27 binds specifically to chemokine receptor 10 (CCR10).


QA State: Curated
Type: Protein
Short Name:


There are no datasets associated with this biomarker.


The following organs have data associated with this biomarker…



Phase: Two
QA State: Under Review


CCL27 was present at higher levels among cases compared to controls with reasonable AUC values.

Performance Comment

CCL27 was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.


This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at if you should have access to this biomarker.


The final report of the 2013 Cancer Biomarkers Bioinformatics Workshop is now available.

Announcement 03/06/2014

Thank you to everyone who helped make the 27th EDRN Steering Committee Meeting a success. We look forward to seeing everyone at the 9th EDRN Scientific Workshop from September 8-11, 2014 in Washington D.C.